Page last updated: 2024-10-29

indomethacin and Bone Cancer

indomethacin has been researched along with Bone Cancer in 36 studies

Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.

Research Excerpts

ExcerptRelevanceReference
" We therefore assessed the effect of Indomethacin and aspirin on some parameters of calcium metabolism in patients with breast cancer."7.65Failure of indomethacin to reduce hypercalcemia in patients with breast cancer. ( Bondy, PK; Coombes, RC; Neville, AM; Powles, TJ, 1976)
" Treatment of mice with 100 micrograms of indomethacin, a potent inhibitor of prostaglandin synthesis, prior to the injection of rhuIL-1 alpha, prevented the increase in number of bone metastases."3.68Effect of IL-1 on experimental bone/bone-marrow metastases. ( Arguello, F; Baggs, RB; Cohen, HJ; Frantz, CN; Graves, BT; Harwell, SE, 1992)
"The responses to Concanavalin A (Con A) of peripheral blood mononuclear cells were studied in 22 patients with malignant bone and soft tissue sarcoma."3.66[Studies on the suppressor cells acting on the mitogen induced blastogenesis in tumor-bearing hosts. II. Suppressor cells in the peripheral blood of patients with malignant bone and soft tissue sarcoma (author's transl)]. ( Takami, M, 1980)
" We therefore assessed the effect of Indomethacin and aspirin on some parameters of calcium metabolism in patients with breast cancer."3.65Failure of indomethacin to reduce hypercalcemia in patients with breast cancer. ( Bondy, PK; Coombes, RC; Neville, AM; Powles, TJ, 1976)
"MCF-7, non-metastatic breast cancer cells, remained dormant when co-cultured with normal human osteoblast and fibroblast growth factor."1.42Dormancy and growth of metastatic breast cancer cells in a bone-like microenvironment. ( Foster, SJ; Grove, CD; Mastro, AM; Norgard, RJ; Sosnoski, DM, 2015)
"Indomethacin is a useful therapy for LCH involving the bony skeleton and may have a role as first-line treatment in single-system bone disease."1.30Use of indomethacin in Langerhans cell histiocytosis. ( Broadbent, V; Munn, SE; Olliver, L; Pritchard, J, 1999)
"Leukotriene B4 (LTB4) is an arachidonic acid lipoxygenase metabolite with well-characterized effects on leukocytes."1.28Effects of leukotrienes on osteoblastic cell proliferation. ( Dziak, R; Ren, W, 1991)
"Indomethacin was given to four patients with hypercalcemia with no effect on serum calcium levels in any cases."1.27Hypercalcemia of cancer in the digestive tract. ( Furuta, S; Monno, S; Nagata, A, 1987)
"Indomethacin may suppress the local acceleration of calcium metabolism."1.26Effects of prostaglandin on experimental bone malignancy and on scintigrams of bone and marrow. ( Ito, Y; Muranaka, A; Nagai, K; Otsuka, N; Terashima, H; Yanagimoto, S, 1981)
"The specific bone resorption-stimulating activity of the HSDM(1) factor extracted from the tumor is high and approximately equal to that of PGE(2) as measured in a bone tissue culture system in vitro."1.25Evidence that the bone resorption-stimulating factor produced by mouse fibrosarcoma cells is prostaglandin E 2 . A new model for the hypercalcemia of cancer. ( Goldhaber, P; Levine, L; Tashjian, AH; Voelkel, EF, 1972)

Research

Studies (36)

TimeframeStudies, this research(%)All Research%
pre-199026 (72.22)18.7374
1990's4 (11.11)18.2507
2000's2 (5.56)29.6817
2010's3 (8.33)24.3611
2020's1 (2.78)2.80

Authors

AuthorsStudies
Mirshahidi, S2
de Necochea-Campion, R2
Moretta, A1
Williams, NL2
Reeves, ME1
Otoukesh, S1
Mirshahidi, HR2
Khosrowpour, S1
Duerksen-Hughes, P1
Zuckerman, LM2
Frames, WL1
Elsissy, JG1
Shields, TG1
Sosnoski, DM1
Norgard, RJ1
Grove, CD1
Foster, SJ1
Mastro, AM1
Díaz-Rodríguez, L1
García-Martínez, O1
Morales, MA1
Rodríguez-Pérez, L1
Rubio-Ruiz, B1
Ruiz, C1
Shoji, M1
Tanabe, N1
Mitsui, N1
Tanaka, H1
Suzuki, N1
Takeichi, O1
Sugaya, A1
Maeno, M1
Hirata, Y1
Uchihashi, M1
Nakashima, H1
Fujita, T2
Matsukura, S1
Matsui, K1
Otsuka, N1
Ito, Y1
Nagai, K1
Terashima, H1
Yanagimoto, S1
Muranaka, A1
Takami, M1
Ritchie, GA1
Rodan, SB1
Rodan, GA1
Simmons, HA1
Walenga, RW1
Feinstein, MB1
Raisz, LG1
Panje, WR1
Chan, CC1
Rodger, IW1
Munn, SE1
Olliver, L1
Broadbent, V1
Pritchard, J1
Chikatsu, N1
Takeuchi, Y1
Tamura, Y1
Fukumoto, S1
Yano, K1
Tsuda, E1
Ogata, E1
Puppo, N1
De Thomatis, M1
Oddone, G1
Goldring, SR1
Dayer, JM1
Krane, SM1
Coombes, RC2
Neville, AM5
Gazet, JC2
Ford, HT1
Nash, AG1
Baker, JW1
Powles, JT1
Easty, GC3
Dowsett, M1
Powles, TJ4
Easty, DM3
Eilon, G1
Mundy, GR1
Galasko, CS1
Bennett, A1
Robertson, RP1
Baylink, DJ1
Metz, SA1
Cummings, KB1
Bondy, PK1
Strausser, HR1
Humes, JL1
Arguello, F1
Baggs, RB1
Graves, BT1
Harwell, SE1
Cohen, HJ1
Frantz, CN1
Ren, W1
Dziak, R1
Monno, S1
Nagata, A1
Furuta, S1
Ritter, MA1
Sieber, JM1
Uchida, T1
Kuwao, S1
Ishibashi, A1
Koshiba, K1
LiVolsi, VA1
Tashjian, AH1
Voelkel, EF1
Levine, L1
Goldhaber, P1
Delaveirre, PH1
Hureau, J1
Grivaux, M1
Chretien, J1
Etienne, JP1
Hart, FD1
Clark, SA1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Atavistic Chemotherapy and Immunotherapy in Advanced, Metastatic, and Otherwise Incurable and Lethal Cancers Under Conventional Treatments[NCT02366884]Phase 2250 participants (Anticipated)Interventional2011-07-26Recruiting
The Effect of Celecoxib on Heterotopic Bone Formation Following Cementless Total Hip Arthroplasty[NCT05648916]200 participants (Anticipated)Observational2022-08-02Enrolling by invitation
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for indomethacin and Bone Cancer

ArticleYear
Selective cyclooxygenase-2 inhibitors as potential therapeutic agents for inflammatory diseases.
    Advances in experimental medicine and biology, 1997, Volume: 407

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone Neoplasms; Cyclooxygenase 1; Cyclooxygenase 2

1997

Other Studies

35 other studies available for indomethacin and Bone Cancer

ArticleYear
Inhibitory Effects of Indomethacin in Human MNNG/HOS Osteosarcoma Cell Line
    Cancer investigation, 2020, Volume: 38, Issue:1

    Topics: Apoptosis; beta Catenin; Bone Neoplasms; Caspase 3; Cell Line, Tumor; Cell Survival; Cyclooxygenase

2020
The effect of non-steroidal anti-inflammatory drugs on osteosarcoma cells.
    European review for medical and pharmacological sciences, 2019, Volume: 23, Issue:6

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone Neoplasms; Cell Line, Tumor; Cell Proliferati

2019
Dormancy and growth of metastatic breast cancer cells in a bone-like microenvironment.
    Clinical & experimental metastasis, 2015, Volume: 32, Issue:4

    Topics: 3T3 Cells; Animals; Bone Neoplasms; Bone Remodeling; Breast Neoplasms; Cell Line, Tumor; Cell Prolif

2015
Effects of indomethacin, nimesulide, and diclofenac on human MG-63 osteosarcoma cell line.
    Biological research for nursing, 2012, Volume: 14, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Bone Neoplasms; Cell Cycle; Cell Differentiation; Cell Line

2012
Lipopolysaccharide stimulates the production of prostaglandin E2 and the receptor Ep4 in osteoblasts.
    Life sciences, 2006, Mar-20, Volume: 78, Issue:17

    Topics: Alkaline Phosphatase; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 1; Cycloo

2006
Specific receptors for epidermal growth factor in human bone tumour cells and its effect on synthesis of prostaglandin E2 by cultured osteosarcoma cell line.
    Acta endocrinologica, 1984, Volume: 107, Issue:1

    Topics: Adult; Alprostadil; Animals; Bone Neoplasms; Bone Resorption; Calcitonin; Cell Line; Child; Cyclic A

1984
Effects of prostaglandin on experimental bone malignancy and on scintigrams of bone and marrow.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1981, Volume: 22, Issue:5

    Topics: Animals; Bone and Bones; Bone Marrow; Bone Neoplasms; Calcium; Diphosphonates; Indomethacin; Mitomyc

1981
[Studies on the suppressor cells acting on the mitogen induced blastogenesis in tumor-bearing hosts. II. Suppressor cells in the peripheral blood of patients with malignant bone and soft tissue sarcoma (author's transl)].
    Nihon Seikeigeka Gakkai zasshi, 1980, Volume: 54, Issue:11

    Topics: Bone Neoplasms; Cell Adhesion; Concanavalin A; Humans; Indomethacin; Monocytes; Sarcoma; Soft Tissue

1980
[Hypercalcemia in non-parathyroid malignant tumors].
    Minerva medica, 1981, May-19, Volume: 72, Issue:20

    Topics: Adrenal Cortex Hormones; Bone Neoplasms; Diuretics; Humans; Hypercalcemia; Indomethacin; Neoplasms;

1981
The direct inhibition of prostaglandin synthetase of human breast cancer tumor tissue by tamoxifen.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1980, Volume: 71

    Topics: Bone Neoplasms; Bone Resorption; Breast Neoplasms; Cyclooxygenase Inhibitors; Dose-Response Relation

1980
Bone resorptive factor produced by osteosarcoma cells with osteoblastic features is PGE2.
    Biochemical and biophysical research communications, 1981, Oct-30, Volume: 102, Issue:4

    Topics: Animals; Bone Neoplasms; Bone Resorption; Cell Line; Chromatography, Thin Layer; Culture Media; Dino

1981
Regression of head and neck carcinoma with a prostaglandin-synthesis inhibitor.
    Archives of otolaryngology (Chicago, Ill. : 1960), 1981, Volume: 107, Issue:11

    Topics: Adult; Aged; Biopsy; Bone and Bones; Bone Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Head and N

1981
Use of indomethacin in Langerhans cell histiocytosis.
    Medical and pediatric oncology, 1999, Volume: 32, Issue:4

    Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Bone Neoplasms; Child; Child, Preschool; Female

1999
Interactions between cancer and bone marrow cells induce osteoclast differentiation factor expression and osteoclast-like cell formation in vitro.
    Biochemical and biophysical research communications, 2000, Jan-19, Volume: 267, Issue:2

    Topics: Animals; Base Sequence; Bone Marrow Cells; Bone Neoplasms; Carrier Proteins; Cell Adhesion; Cocultur

2000
[Clinical use of indomethacin administered intravenously in the analgesic treatment of neoplasms with bone metastases].
    La Clinica terapeutica, 1975, Jun-30, Volume: 73, Issue:6

    Topics: Adolescent; Adult; Aged; Bone Neoplasms; Female; Humans; Indomethacin; Infusions, Parenteral; Inject

1975
Anti-inflammatory drugs and tumour growth.
    Lancet (London, England), 1979, Feb-24, Volume: 1, Issue:8113

    Topics: Animals; Aspirin; Bone Neoplasms; Carcinogens; Drug Evaluation; Humans; Indomethacin; Neoplasm Metas

1979
Regulation of hormone-induced cyclic AMP response to parathyroid hormone and prostaglandin E2 in cells cultured from human giant cell tumors of bone.
    Calcified tissue international, 1979, Volume: 29, Issue:3

    Topics: 1-Methyl-3-isobutylxanthine; Bone Neoplasms; Cells, Cultured; Cyclic AMP; Giant Cell Tumors; Humans;

1979
Agents affecting osteolysis in patients with breast cancer.
    Cancer chemotherapy and pharmacology, 1979, Volume: 3, Issue:1

    Topics: Anti-Inflammatory Agents; Aspirin; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Calcitonin; Fe

1979
In vitro osteolysis by human breast tumours.
    Proceedings of the Royal Society of Medicine, 1977, Volume: 70, Issue:3

    Topics: Aspirin; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Calcium; Female; Humans; In Vitro Techni

1977
Direct resorption of bone by human breast cancer cells in vitro.
    Nature, 1978, Dec-14, Volume: 276, Issue:5689

    Topics: Bone Neoplasms; Bone Resorption; Breast Neoplasms; Cell Line; Female; Humans; Indomethacin; Neoplasm

1978
Relationship of bone destruction in skeletal metastases to osteoclast activation and prostaglandins.
    Nature, 1976, Oct-07, Volume: 263, Issue:5577

    Topics: Animals; Bone Neoplasms; Bone Resorption; Indomethacin; Lung Neoplasms; Neoplasm Metastasis; Neoplas

1976
Plasma prostaglandin E in patients with cancer with and without hypercalcemia.
    The Journal of clinical endocrinology and metabolism, 1976, Volume: 43, Issue:6

    Topics: Bone Neoplasms; Female; Humans; Hypercalcemia; Indomethacin; Male; Neoplasm Metastasis; Neoplasms; P

1976
Failure of indomethacin to reduce hypercalcemia in patients with breast cancer.
    Prostaglandins, 1976, Volume: 12, Issue:6

    Topics: Aspirin; Bone Neoplasms; Breast Neoplasms; Calcium; Creatinine; Female; Humans; Hydroxyproline; Hype

1976
Prostaglandin synthesis inhibition: effect on bone changes and sarcoma tumor induction in balb/c mice.
    International journal of cancer, 1975, May-15, Volume: 15, Issue:5

    Topics: Animals; Bone Neoplasms; Immunosuppression Therapy; Indomethacin; Male; Mice; Moloney murine leukemi

1975
Effect of IL-1 on experimental bone/bone-marrow metastases.
    International journal of cancer, 1992, Nov-11, Volume: 52, Issue:5

    Topics: Animals; Bone Marrow Diseases; Bone Neoplasms; Granulocyte-Macrophage Colony-Stimulating Factor; Ind

1992
Effects of leukotrienes on osteoblastic cell proliferation.
    Calcified tissue international, 1991, Volume: 49, Issue:3

    Topics: Animals; Benzoquinones; Bone Neoplasms; Cell Division; Cells, Cultured; Culture Media, Serum-Free; D

1991
Hypercalcemia of cancer in the digestive tract.
    Journal of clinical gastroenterology, 1987, Volume: 9, Issue:1

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Female; Gastrointestinal Neoplasms; Humans; Hypercalcemia;

1987
Prophylactic indomethacin for the prevention of heterotopic bone formation following total hip arthroplasty.
    Clinical orthopaedics and related research, 1985, Issue:196

    Topics: Adult; Aged; Bone and Bones; Bone Neoplasms; Choristoma; Female; Hip Prosthesis; Humans; Indomethaci

1985
Elevated prostaglandin and indomethacin-responsive hypercalcemia in a patient with malignant pheochromocytoma.
    The Journal of urology, 1985, Volume: 134, Issue:4

    Topics: Adrenal Gland Neoplasms; Bone Neoplasms; Calcium; Humans; Hypercalcemia; Indomethacin; Male; Middle

1985
Anti-metastatic effect of aspirin.
    Lancet (London, England), 1973, Jul-14, Volume: 2, Issue:7820

    Topics: Animals; Aspirin; Bone Neoplasms; Bone Resorption; Carcinoma 256, Walker; Indomethacin; Lysosomes; N

1973
Anti-metastatic effect of aspirin.
    Lancet (London, England), 1973, Aug-04, Volume: 2, Issue:7823

    Topics: Animals; Aspirin; Bone Neoplasms; Bone Resorption; In Vitro Techniques; Indomethacin; Mice; Neoplasm

1973
Evidence that the bone resorption-stimulating factor produced by mouse fibrosarcoma cells is prostaglandin E 2 . A new model for the hypercalcemia of cancer.
    The Journal of experimental medicine, 1972, Dec-01, Volume: 136, Issue:6

    Topics: Animals; Bone Neoplasms; Bone Resorption; Calcium; Cells, Cultured; Clone Cells; Culture Techniques;

1972
[Iatrogenic gastroduodenal ulcerations. Corticosteroids excluded].
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1973, Nov-20, Volume: 49, Issue:47

    Topics: Aged; Bone Neoplasms; Carcinoma, Squamous Cell; Cyclophosphamide; Duodenal Ulcer; Female; Humans; In

1973
Analgesics and non-steroid anti-inflammatory agents in rheumatic disease.
    The Practitioner, 1972, Volume: 208, Issue:243

    Topics: Analgesics; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspirin; Bone Neoplasms; Gout; Humans;

1972
The inhibition by aspirin and indomethacin of osteolytic tumor deposits and hypercalcaemia in rats with Walker tumour, and its possible application to human breast cancer.
    British journal of cancer, 1973, Volume: 28, Issue:4

    Topics: Animals; Aspirin; Bone and Bones; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Calcium; Calciu

1973